These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Detrol LA and Diropan XL for overactive bladder. Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473 [No Abstract] [Full Text] [Related]
3. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder? Hartnett NM; Saver BG J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700 [No Abstract] [Full Text] [Related]
4. RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. Ellsworth P J Urol; 2003 Sep; 170(3):928; author reply 928. PubMed ID: 12913741 [No Abstract] [Full Text] [Related]
5. Methodologic shortcomings inherent in a post-hoc analysis. Staskin DR Curr Urol Rep; 2002 Dec; 3(6):431-3. PubMed ID: 12425862 [No Abstract] [Full Text] [Related]
6. Oxybutynin transdermal (Oxytrol) for overactive bladder. Med Lett Drugs Ther; 2003 May; 45(1156):38-9. PubMed ID: 12736598 [No Abstract] [Full Text] [Related]
7. Anticholinergic drugs for overactive bladder. Kripke C Am Fam Physician; 2006 Jan; 73(1):66. PubMed ID: 16417066 [No Abstract] [Full Text] [Related]
8. [Therapy of bladder weakness]. Wagenlehner FM Dtsch Med Wochenschr; 2005 Jan; 130(3):118. PubMed ID: 15650964 [No Abstract] [Full Text] [Related]
9. Advances in medical management of overactive bladder. Richelson E; Elliott DS Mayo Clin Proc; 2003 Jun; 78(6):681-3. PubMed ID: 12934775 [No Abstract] [Full Text] [Related]
10. Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence? Blonski J J Fam Pract; 2001 Dec; 50(12):1017. PubMed ID: 11742595 [No Abstract] [Full Text] [Related]
12. Treatment can lead to a long dry spell. Starr CH Bus Health; 2002; Spec No():15-9, 24. PubMed ID: 11974567 [No Abstract] [Full Text] [Related]
13. A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder. Arikian SR; Casciano J; Doyle JJ; Tarride JE; Casciano RN Manag Care Interface; 2000 Feb; 13(2):88-94. PubMed ID: 11067391 [TBL] [Abstract][Full Text] [Related]
14. [Detrusitol - a drug of choice in impaired function of the bladder and urinary incontinence]. Mitova E; Akush Ginekol (Sofiia); 2000; 39 Suppl 2():23-4. PubMed ID: 11188011 [No Abstract] [Full Text] [Related]
15. Medical treatment of overactive bladder. Rackley R; Wein A; Nelson D Mayo Clin Proc; 2001 Nov; 76(11):1179-80. PubMed ID: 11702910 [No Abstract] [Full Text] [Related]
16. New treatment options for overactive bladder and incontinence. Newman DK Director; 2002; 10(3):74-6. PubMed ID: 12116753 [No Abstract] [Full Text] [Related]
17. Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence. Reinberg Y; Crocker J; Wolpert J; Vandersteen D J Urol; 2003 Jan; 169(1):317-9. PubMed ID: 12478180 [TBL] [Abstract][Full Text] [Related]
18. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial. Appell RA Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340 [No Abstract] [Full Text] [Related]
19. Medication update. Slagle M South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243 [No Abstract] [Full Text] [Related]
20. Treatments for overactive bladder. Newton M; Kosier JH; Smith D Urol Nurs; 2000 Aug; 20(4):267-8. PubMed ID: 11998091 [No Abstract] [Full Text] [Related] [Next] [New Search]